CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 120 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,393,015 | +18499.5% | 1,568,948 | +13559.7% | 0.00% | – |
Q2 2023 | $125,772 | -35.9% | 11,486 | -49.0% | 0.00% | – |
Q1 2023 | $196,270 | +178.5% | 22,508 | +100.2% | 0.00% | – |
Q4 2022 | $70,475 | +80.7% | 11,240 | +0.2% | 0.00% | – |
Q3 2022 | $39,000 | +18.2% | 11,215 | 0.0% | 0.00% | – |
Q2 2022 | $33,000 | -5.7% | 11,215 | -0.5% | 0.00% | – |
Q1 2022 | $35,000 | +3400.0% | 11,275 | +4617.6% | 0.00% | – |
Q1 2021 | $1,000 | – | 239 | +23800.0% | 0.00% | – |
Q1 2020 | $0 | – | 1 | -97.4% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 39 | -88.5% | 0.00% | – |
Q3 2019 | $2,000 | – | 339 | +769.2% | 0.00% | – |
Q2 2019 | $0 | -100.0% | 39 | -100.0% | 0.00% | – |
Q1 2019 | $1,630,000 | -62.2% | 122,739 | -77.6% | 0.00% | -100.0% |
Q4 2018 | $4,310,000 | -77.0% | 547,528 | -67.6% | 0.00% | -50.0% |
Q3 2018 | $18,741,000 | -42.2% | 1,691,425 | -30.0% | 0.00% | -50.0% |
Q2 2018 | $32,421,000 | -55.3% | 2,415,837 | -56.7% | 0.00% | -55.6% |
Q1 2018 | $72,538,000 | +238.8% | 5,584,117 | +139.9% | 0.01% | +200.0% |
Q4 2017 | $21,413,000 | +14.1% | 2,327,520 | 0.0% | 0.00% | +50.0% |
Q3 2017 | $18,759,000 | – | 2,327,520 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management IV, LLC | 2,023,369 | $27,154,000 | 9.26% |
Omega Fund Management, LLC | 551,477 | $7,401,000 | 5.46% |
Foresite Capital Management III, LLC | 1,562,040 | $20,963,000 | 4.51% |
Versant Venture Management, LLC | 1,048,601 | $14,072,225,000 | 4.39% |
Boxer Capital, LLC | 2,094,000 | $28,101,000 | 3.18% |
Opaleye Management Inc. | 697,500 | $9,360,000 | 2.42% |
Abingworth LLP | 273,417 | $3,667,000 | 2.10% |
DAFNA Capital Management LLC | 294,511 | $3,952,000 | 1.85% |
NEXTHERA CAPITAL LP | 828,655 | $11,121,000 | 1.72% |
Vivo Capital, LLC | 906,000 | $12,158,000 | 1.57% |